IN2015DN03077A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03077A
IN2015DN03077A IN3077DEN2015A IN2015DN03077A IN 2015DN03077 A IN2015DN03077 A IN 2015DN03077A IN 3077DEN2015 A IN3077DEN2015 A IN 3077DEN2015A IN 2015DN03077 A IN2015DN03077 A IN 2015DN03077A
Authority
IN
India
Application number
Inventor
A Bourke Frederic
Original Assignee
Immunolight Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39827110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN03077(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunolight Llc filed Critical Immunolight Llc
Publication of IN2015DN03077A publication Critical patent/IN2015DN03077A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/008—Two-Photon or Multi-Photon PDT, e.g. with upconverting dyes or photosensitisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0656—Chemical light sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1089—Electrons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN3077DEN2015 2007-04-08 2015-04-13 IN2015DN03077A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91066307P 2007-04-08 2007-04-08
US11/935,655 US9358292B2 (en) 2007-04-08 2007-11-06 Methods and systems for treating cell proliferation disorders
PCT/US2008/059561 WO2008124681A2 (en) 2007-04-08 2008-04-07 Methods and systems for treating cell proliferation disorders

Publications (1)

Publication Number Publication Date
IN2015DN03077A true IN2015DN03077A (en) 2015-10-02

Family

ID=39827110

Family Applications (2)

Application Number Title Priority Date Filing Date
IN3077DEN2015 IN2015DN03077A (en) 2007-04-08 2015-04-13
IN3080DEN2015 IN2015DN03080A (en) 2007-04-08 2015-04-13

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN3080DEN2015 IN2015DN03080A (en) 2007-04-08 2015-04-13

Country Status (12)

Country Link
US (5) US9358292B2 (en)
EP (2) EP2150549A4 (en)
JP (1) JP2010523690A (en)
KR (6) KR102065832B1 (en)
CN (2) CN104027809B (en)
AR (1) AR066899A1 (en)
AU (1) AU2008237121B2 (en)
CA (2) CA2682686C (en)
CL (3) CL2008000997A1 (en)
IN (2) IN2015DN03077A (en)
TW (2) TWI654008B (en)
WO (1) WO2008124681A2 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358292B2 (en) * 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
WO2015195896A1 (en) * 2014-06-19 2015-12-23 Immunolight, Llc Methods and systems for treating cell proliferation disorders with psoralen derivatives
US8383836B2 (en) 2009-04-21 2013-02-26 Duke University Methods and systems for treating cell proliferation disorders with psoralen derivatives
US8951561B2 (en) 2007-08-06 2015-02-10 Duke University Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP)
US9488916B2 (en) 2007-04-08 2016-11-08 Immunolight, Llc. Interior energy-activation of photo-reactive species inside a medium or body
US20090104212A1 (en) * 2007-08-06 2009-04-23 Immunolight Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption
CL2009000560A1 (en) 2008-03-11 2010-02-19 Univ Duke A method of hardening a radiation hardenable medium comprising placing a composition within an object to be hardened, applying at least one chosen from x-ray, gamma ray, or electron beam through the object and within the composition.
US9907976B2 (en) 2011-07-08 2018-03-06 Immunolight, Llc Phosphors and scintillators for light stimulation within a medium
CA3095369C (en) * 2008-04-04 2023-09-26 Immunolight, Llc Non-invasive systems and methods for in-situ photobiomodulation
US8770203B2 (en) 2008-07-14 2014-07-08 Immunolight, Llc. Advanced methods and systems for treating cell proliferation disorders
CA2754217A1 (en) * 2009-03-02 2010-09-10 Massachusetts Institute Of Technology Methods and systems for treatment and/or diagnosis
JP5908396B2 (en) * 2009-04-21 2016-04-26 イミュノライト・エルエルシー Non-invasive energy upconversion method and system for in situ photobiomodulation
US20100312312A1 (en) * 2009-06-09 2010-12-09 Gary Wayne Jones Method for selective photodynamic therapy and light source for implementation thereof
WO2011011782A1 (en) * 2009-07-24 2011-01-27 Duke University Functionalized metal-coated energy converting nanoparticles, methods for production thereof and methods for use
CN107149689A (en) 2009-11-10 2017-09-12 免疫之光有限责任公司 The system solidified to radiation-hardenable medium and the method for producing light
PL3210591T3 (en) 2010-08-27 2019-08-30 Sienna Biopharmaceuticals, Inc. Compositions and methods for targeted thermomodulation
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
EP2685976B1 (en) * 2011-03-17 2017-12-27 Tel HaShomer Medical Research Infrastructure and Services Ltd. Quinolone analogs for treating autoimmune diseases
US20130012754A1 (en) * 2011-07-07 2013-01-10 Empire Technology Development Llc Microwave induced photodynamic therapy
ES2629903T3 (en) 2012-10-11 2017-08-16 Nanocomposix, Inc. Compositions and method of silver nanoplates
KR101536325B1 (en) * 2013-10-16 2015-07-14 주식회사 지니스 The thermosensitizer composition for electromagnetic wave-based hyperthermia and its use to treat cancer
EP3074391B1 (en) 2013-11-28 2019-07-31 Tel Hashomer Medical Research Infrastructure And Services Ltd. Rna polymerase i inhibitors and uses thereof
EP3097108B8 (en) * 2014-01-23 2021-04-07 Immunolight, LLC Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
WO2016028680A1 (en) * 2014-08-18 2016-02-25 Immunolight, Llc. Non-invasive systems and methods for selective activation of photoreactive responses
US20180071024A1 (en) * 2015-03-20 2018-03-15 Sienna Biopharmaceuticals, Inc. Enhanced efficacy and targeted topical delivery of drugs to skin with nanoparticles
US10383939B2 (en) 2015-03-20 2019-08-20 The Regents Of The University Of Colorado, A Body Corporate Light-activated compositions and methods using the same
KR102687638B1 (en) * 2015-08-04 2024-07-22 벡션 테라퓨틱스 엘엘씨 Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals
WO2017040805A1 (en) * 2015-09-01 2017-03-09 Howard Hughes Medical Institute Ion-activated photolabile compounds
EP3448292A4 (en) * 2016-04-25 2020-04-08 Immunolight, Llc. Insertion devices and systems for production of emitted light internal to a medium and methods for their use
AU2017384425B2 (en) * 2016-12-21 2023-08-31 Nanobiotix Nanoparticles for use for treating a neuronal disorder
CA3131865A1 (en) 2019-03-04 2020-09-10 Immunolight, Llc. Energy augment structures for use with energy emitters and collectors
CN110115761B (en) * 2019-05-09 2023-06-16 英诺激光科技股份有限公司 Method for preparing vaccine by using laser and carrier technology
US20230256094A1 (en) * 2020-06-30 2023-08-17 Board Of Regents, The University Of Texas System Cancer radiosensitization by in situ formation of gold nanoparticles and/or gold nanoclusters
US20220096634A1 (en) * 2020-09-30 2022-03-31 David A. Jernigan Method of manipulating phages within the body to attack infectious target cells
CN115414354A (en) * 2022-08-29 2022-12-02 西南医科大学 Application of xanthotoxin in preparation of medicine for treating thrombocytopenia
CN116925997B (en) * 2023-07-27 2024-04-02 湖北医药学院 Application of levofloxacin in preparing medicine for promoting cell proliferation

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045A (en) 1850-01-22 Chitck foe
US124A (en) 1837-02-10 Improvement in the machine for weighing heavy bodies
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4748120A (en) 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4838852A (en) 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US5091385A (en) 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds
US5177073A (en) 1988-09-30 1993-01-05 Baylor Research Institute Therapeutic compositions derived from photoactive compounds
US5216176A (en) 1989-01-23 1993-06-01 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US4979935A (en) 1989-02-21 1990-12-25 Quantex Corporation Method of photodynamic therapy employing electron trapping material
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US5807881A (en) 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
EP0675955A1 (en) 1992-12-23 1995-10-11 Iowa State University Research Foundation, Inc. Molecular flashlight
US6121425A (en) 1994-07-29 2000-09-19 Nanoprobes, Inc. Metal-lipid molecules
US5521289A (en) 1994-07-29 1996-05-28 Nanoprobes, Inc. Small organometallic probes
US5728590A (en) 1994-07-29 1998-03-17 Nanoprobes, Inc. Small organometallic probes
US6235508B1 (en) 1995-06-07 2001-05-22 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
IT1275571B (en) 1995-07-19 1997-08-07 Consiglio Nazionale Ricerche FLUOROGENIC SUBSTRATES SUSCEPTIBLE FOR PHOTOACTIVATION AFTER ENZYMATIC TRANSFORMATION SUITABLE FOR DIAGNOSIS AND PHOTODYNAMIC CANCER THERAPY
JP3689939B2 (en) 1995-07-28 2005-08-31 豊田合成株式会社 Photocatalytic device
US20030022105A1 (en) * 1995-09-06 2003-01-30 Paras N. Prasad Two -photon upconverting dyes and applications
AU717624B2 (en) 1996-03-29 2000-03-30 Therakos, Inc. Photopheresis treatment of chronic HCV infections
JP2000510101A (en) 1996-03-29 2000-08-08 セラコス・インコーポレーテツド Photopheresis treatment of leukocytes
JPH09299937A (en) 1996-05-09 1997-11-25 Daikin Ind Ltd Treating device for material
US5829448A (en) 1996-10-30 1998-11-03 Photogen, Inc. Method for improved selectivity in photo-activation of molecular agents
US7390668B2 (en) 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
US5957960A (en) 1997-05-05 1999-09-28 Light Sciences Limited Partnership Internal two photon excitation device for delivery of PDT to diffuse abnormal cells
US6071944A (en) 1997-11-12 2000-06-06 Bowling Green State University Method of treatment of pigmented cancer cells utilizing photodynamic therapy
US20030022170A1 (en) 1998-03-06 2003-01-30 Millenium Pharmaceuticals, Inc. Novel fibroblast growth factors and therapeutic and diagnostic uses therefor
US6075155A (en) 1998-06-22 2000-06-13 Rensselaer Polytechnic Institute Radiation-curable cycloaliphatic epoxy compounds, uses thereof, and compositions containing them
WO2000006244A2 (en) 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
US6132958A (en) * 1999-05-27 2000-10-17 The Rockefeller University Fluorescent bead for determining the temperature of a cell and methods of use thereof
US7332344B2 (en) 1999-12-01 2008-02-19 Photonic Research Systems Limited Luminescence assays
EP1239795B1 (en) 1999-12-23 2006-12-06 Edwards Lifesciences Corporation Enhanced visualization of medical implants
US6719778B1 (en) * 2000-03-24 2004-04-13 Endovascular Technologies, Inc. Methods for treatment of aneurysms
CN1308961A (en) 2001-02-16 2001-08-22 北京飞天兆业科技有限责任公司 Medicine for treating dermatopathy by photochemical therapy
US20020127224A1 (en) 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
US7364872B1 (en) 2001-03-30 2008-04-29 Nanoprobes Test methods using enzymatic deposition and alteration of metals
US6670113B2 (en) 2001-03-30 2003-12-30 Nanoprobes Enzymatic deposition and alteration of metals
WO2002094271A1 (en) 2001-05-15 2002-11-28 Faulk Pharmaceuticals, Inc. Targeted delivery of bioaffecting compounds for the treatment of cancer
US7008559B2 (en) 2001-06-06 2006-03-07 Nomadics, Inc. Manganese doped upconversion luminescence nanoparticles
US7303578B2 (en) 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
GB0126236D0 (en) 2001-11-01 2002-01-02 Univ East Anglia Photosensitiser functionalised nanoparticles
AU2002332697A1 (en) 2001-12-12 2003-06-23 Leon J. Lewandowski Photophoretic auto immune stimulation
AU2002359870A1 (en) * 2001-12-28 2003-07-24 Oregon Health And Science University Agents that recognize src when phosphorylated at serine 17
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US20050059028A1 (en) 2002-11-18 2005-03-17 Genospectra, Inc. RNAi-based sensors, caged interfering RNAs, and methods of use thereof
US7695738B2 (en) * 2003-02-19 2010-04-13 Academia Sinica Carbohydrate encapsulated nanoparticles
US20050043233A1 (en) 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
CN1874789A (en) 2003-09-23 2006-12-06 光科学公司 Conjugates for photodynamic therapy
US20060067941A1 (en) 2003-12-05 2006-03-30 Secretary, Department Of Health & Human Services Nanotubes for cancer therapy and diagnostics
CN1893976A (en) 2003-12-17 2007-01-10 皇家飞利浦电子股份有限公司 Radiation therapy and medical imaging using uv emitting nanoparticles
FR2869803B1 (en) 2004-05-10 2006-07-28 Nanobiotix Sarl ACTIVE PARTICLES, PREPARATION AND USES
US20060067889A1 (en) 2004-09-27 2006-03-30 Light Sciences Corporation Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
WO2006037081A2 (en) 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
JPWO2006038449A1 (en) 2004-10-05 2008-07-31 日本板硝子株式会社 Luminescent body in which phosphor fine particles are dispersed, method for producing the same, and material or article containing the luminous body
FR2877571B1 (en) 2004-11-05 2007-04-13 Nanobiotix Sarl NANOPARTICLES WITH INTRACELLULAR TARGETING ELEMENT, PREPARATION AND USES
NZ572334A (en) 2004-12-22 2010-02-26 Omj Ireland Ltd Phototherapy compositions comprising 8-methoxypsoralen and 2-ethylhexyl p-dimethylaminobenzoate
US7397043B2 (en) 2005-01-26 2008-07-08 Nomadics, Inc. Standoff optical detection platform based on surface plasmon-coupled emission
US20070218049A1 (en) 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same
US7538329B2 (en) 2005-02-02 2009-05-26 Nomadics, Inc. Energy-transfer nanocomposite materials and methods of making and using same
US20060222595A1 (en) * 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
WO2006113192A2 (en) * 2005-04-06 2006-10-26 Drexel University Functional nanoparticle filled carbon nanotubes and methods of their production
IL168184A (en) 2005-04-21 2011-11-30 Univ Ariel Res & Dev Co Ltd Use of a ligand-photosensitizer conjugate in combination with a chemiluminescent agent in the manufacture of a medicament for photodynamic therapy
EP1779891A1 (en) 2005-10-28 2007-05-02 Abdula Kurkayev Method of activating a photosensitizer
JPWO2007108512A1 (en) 2006-03-22 2009-08-06 毅一郎 角 Method for producing metal coating material and metal coating material
US20070243137A1 (en) 2006-04-18 2007-10-18 Nanoprobes, Inc. Cell and sub-cell methods for imaging and therapy
GB0712287D0 (en) 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
US8328785B2 (en) 2006-09-18 2012-12-11 The University Of Houston System Use of nanoparticles in the photodynamic treatment of tumors
US7906147B2 (en) 2006-10-12 2011-03-15 Nanoprobes, Inc. Functional associative coatings for nanoparticles
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
US8951561B2 (en) * 2007-08-06 2015-02-10 Duke University Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP)
US20090104212A1 (en) 2007-08-06 2009-04-23 Immunolight Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption
WO2009064845A2 (en) 2007-11-16 2009-05-22 Bernstein Eric F Sterilizing compositions comprising phosphors for converting electromagnetic radiation to uvc radiation and methods for using the same
CL2009000560A1 (en) 2008-03-11 2010-02-19 Univ Duke A method of hardening a radiation hardenable medium comprising placing a composition within an object to be hardened, applying at least one chosen from x-ray, gamma ray, or electron beam through the object and within the composition.
US8431041B2 (en) 2008-03-31 2013-04-30 Stc.Unm Halide-based scintillator nanomaterial
CA3095369C (en) * 2008-04-04 2023-09-26 Immunolight, Llc Non-invasive systems and methods for in-situ photobiomodulation
US8770203B2 (en) * 2008-07-14 2014-07-08 Immunolight, Llc. Advanced methods and systems for treating cell proliferation disorders
EP3097108B8 (en) * 2014-01-23 2021-04-07 Immunolight, LLC Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
CA3002394A1 (en) * 2015-10-19 2017-04-27 Immunolight, Llc X-ray psoralen activated cancer therapy (x-pact)

Also Published As

Publication number Publication date
CA2935870A1 (en) 2008-10-16
US20140341845A1 (en) 2014-11-20
TWI530308B (en) 2016-04-21
EP2150549A4 (en) 2014-09-03
CA2935870C (en) 2021-07-20
JP2010523690A (en) 2010-07-15
EP2150549A2 (en) 2010-02-10
CL2008000997A1 (en) 2008-10-03
CA2682686C (en) 2016-12-20
WO2008124681A3 (en) 2009-02-05
CL2015000382A1 (en) 2015-04-24
CN101711246A (en) 2010-05-19
TW201519929A (en) 2015-06-01
CN101711246B (en) 2014-06-25
US20080248001A1 (en) 2008-10-09
AU2008237121A1 (en) 2008-10-16
CA2682686A1 (en) 2008-10-16
IN2015DN03080A (en) 2015-10-02
US9682146B2 (en) 2017-06-20
KR20170067904A (en) 2017-06-16
KR101925176B1 (en) 2018-12-04
KR20200001607A (en) 2020-01-06
KR20140141725A (en) 2014-12-10
US10398777B2 (en) 2019-09-03
US20140242035A1 (en) 2014-08-28
WO2008124681A4 (en) 2009-12-23
TWI654008B (en) 2019-03-21
TW200902114A (en) 2009-01-16
CN104027809A (en) 2014-09-10
US20190336605A1 (en) 2019-11-07
EP3299031B1 (en) 2022-06-08
US20170258908A1 (en) 2017-09-14
CL2015000383A1 (en) 2015-04-24
CN104027809B (en) 2017-08-25
KR20170127045A (en) 2017-11-20
US9352040B2 (en) 2016-05-31
EP3299031A1 (en) 2018-03-28
KR20100022951A (en) 2010-03-03
US9358292B2 (en) 2016-06-07
KR102065832B1 (en) 2020-01-13
KR20170015570A (en) 2017-02-08
AU2008237121B2 (en) 2013-10-10
AR066899A1 (en) 2009-09-23
US11103580B2 (en) 2021-08-31
WO2008124681A2 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
IN2015DN03077A (en)
CN300727738S (zh) 砂带抛光机的吸尘罩
CN300730067S (zh) 显示器(ul-1731)
CN300728860S (zh) 沙发(630)
CN300726087S (zh) 扑克牌盒(大赢家)
CN300726315S (zh) 餐椅(b26)
CN300726333S (zh) 沙发(1068)
CN300726510S (zh) 椅座(0626-1)
CN300726718S (zh) 刀柄
CN300726738S (zh) 体育用品模具(4)
CN300726916S (zh) 包装盒(叶面好)
CN300728768S (zh) 墙纸(22)
CN300726956S (zh) 包装盒(黄金搭档中老年型)
CN300727127S (zh) 饮料包装袋(2)
CN300727232S (zh) 入侵探测器
CN300729597S (zh) 食品包装袋(c)
CN300727397S (zh) 汽车前保险杠
CN300727437S (zh) 燃油锅炉电机
CN300727461S (zh) 充电座(一)
CN300727574S (zh) Dvd播放机
CN300727581S (zh) 收录放音机(gh-642)
CN300727716S (zh) 搅拌车
CN300727733S (zh) 吸尘器机体
CN300727266S (zh) 自由组合饰物配件(tg109-a)
CN300729888S (zh) 汽车c柱装饰板(6)